Halozyme Therapeutics shares owned by Congress Asset Management
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Congress Asset Management
from 13F filings
Historical chart of Congress Asset Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Congress Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Congress Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $105M | 1.4M | 73.34 |
| 2025-06-30 | $96M | 1.8M | 52.02 |
| 2025-03-31 | $136M | 2.1M | 63.81 |
| 2024-12-31 | $94M | 2.0M | 47.81 |
| 2024-09-30 | $139M | 2.4M | 57.24 |
| 2024-06-30 | $23M | 445k | 52.36 |
| 2024-03-31 | $17M | 408k | 40.68 |
| 2023-12-31 | $13M | 351k | 36.96 |
| 2023-09-30 | $12M | 304k | 38.20 |
| 2023-06-30 | $10M | 289k | 36.07 |